Back to News
Market Impact: 0.2

Repligen Corp (RGEN) Shares Fall 4.1% -- What GF Score of 83 Tells Investors

Company FundamentalsMarket Technicals & FlowsHealthcare & Biotech

Repligen Corp (RGEN) fell 4.1% to $126.67 on June 22, 2026, with the stock trading well below its 52-week high of $175.77 and above its low of $100.99. The article provides no operational or fundamental catalyst, so the move appears to be a price/positioning-driven decline rather than a news-driven re-rating.

Analysis

Repligen Corp (RGEN) fell 4.1% to $126.67 on June 22, 2026, with the stock trading well below its 52-week high of $175.77 and above its low of $100.99. The article provides no operational or fundamental catalyst, so the move appears to be a price/positioning-driven decline rather than a news-driven re-rating.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request Demo

Market Sentiment

Overall Sentiment

mildly negative

Sentiment Score

-0.15

Ticker Sentiment

RGEN-0.15